Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

PATIENTS GAIN ACCESS TO INNOVATIVE NEW PROCEDURE FOR TREATING KNEE OSTEOARTHRITIS AS HCA UK PARTNERS WITH CONTURA ORTHOPAEDICS

London, September 2022; Contura Orthopaedics Ltd is pleased to announce that a major hospital group has signed up to Arthrosamid, allowing clinicians to offer this novel procedure to its patients in London and across the UK.

musculoskeletal disorders in addition to sporting injuries and complaints at its state-of-the-art facility located on Tottenham Court Road in Central London. The treatment will be rolled out across other facilities across the HCA Healthcare UK group in the coming months.

Arthrosamid is a polyacrylamide hydrogel first developed by Contura International Ltd. It is a long-lasting intra-articular injection approved in Europe for the treatment of knee OA. The treatment has the potential to change the present care pathway for managing OA, which affects approximately

Beyond Surgery: Exploring the Most Effective Non-Surgical Treatments for Advanced Knee Osteoarthritis in the UK

Advanced knee osteoarthritis causes severe pain and mobility loss due to cartilage deterioration, but surgery isn’t the only solution. Effective management includes tailored exercises like leg raises and hamstring curls to strengthen muscles safely, anti-inflammatory diets, and supplements such as glucosamine and omega-3s. Innovative non-surgical treatments, including orthobiologics like platelet-rich plasma therapy, offer promising relief. Avoiding high-impact activities and adopting lifestyle changes like low-impact cardio help maintain joint health. Consulting healthcare professionals for personalised care ensures optimal outcomes and quality of life for those with advanced osteoarthritis in the UK.

Read More »

Beyond the Hype: Can Gel Injections Really Ease Bone-on-Bone Knee Pain?

This article explores the effectiveness of gel injections, including hyaluronic acid and polyacrylamide hydrogel (PAAG), for managing severe ‘bone-on-bone’ knee osteoarthritis. While gel injections aim to lubricate joints and reduce pain, scientific evidence shows mixed and often modest benefits, especially in advanced cartilage loss. PAAG may offer slightly longer-lasting relief compared to traditional treatments, but no injection regrows cartilage or fully cures severe osteoarthritis. Treatment success depends on factors like age, weight, and cartilage condition. Gel injections can be part of a broader management plan alongside medications, physiotherapy, and surgery. Patients are encouraged to set realistic expectations and discuss treatment options thoroughly with their healthcare providers to find the most suitable approach.

Read More »